The supplement market shows 6.8-12.87% annual growth, reflecting consumer preference for accessible options
Because levels are often quite low before a deficiency is recognized, it can take some time for serum concentrations to even out and symptoms to subside
GLP-1 medications such as Wegovy, Ozempic, and Zepbound have become increasingly popular for treating obesity and Type 2 diabetes, but insurance coverage for these medications remains inconsistent and financially challenging for consumers who have resorted to getting their GLP1s through other avenues
Overall, the findings provide cautious, low-certainty reassurance regarding inadvertent maternal exposure, particularly during early pregnancy, but do not establish that these drugs are safe for routine use throughout pregnancy
Though only a few years old, many previous analyses were outdated and did not reflect more recent findings, such as the cardiovascular benefits of these drugs